Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 322,
Modbury North,
South Australia 5092

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 242KB)
Why become a member?

Medical Marijuana Great For Migraine, Fibromyalgia And Irritable Bowel Syndrome, Survey Finds

Saturday 28 November 2015

 

From the National Pain Report:

 

Marijuana
 

Medical Marijuana Great for Migraine, Fibromyalgia and Irritable Bowel Syndrome, Survey Finds

Posted on November 27, 2015

One-hundred percent (100%) of people with migraine headache, fibromyalgia or irritable bowel syndrome who use medical marijuana for a minimum of 30 days report a reduction in pain and discomfort, a survey of 621 by the Care By Design found.

People included in the survey suffer from a range of different conditions, and some suffer from multiple conditions, including:

  • Psychiatric disorders (24%)
    • Anxiety, PTSD, depression, autism, addiction
  • Inflammatory conditions (19%)
    • Arthritis, rheumatism, Crohn’s disease, irritable bowel syndrome
  • Pain (14%)
    • Neuropathic pain, headaches, migraines, fibromyalgia
  • Central nervous system disorders (12%)
    • Multiple sclerosis, epilepsy, spinal cord injury, Parkinson’s, Traumatic Brain Injury (TBI)
  • Cancer-related symptoms (12%)

Cannabis and Well-Being

“A majority of patients (88.2%) reported that cannabis therapy improved their overall sense of wellbeing,” the study found. “Patients with fibromyalgia, headaches and migraines, PTSD and anxiety reported the greatest improvement in general wellbeing (as compared to other patient groups).”

Cannabis and Pain

Cannibis Pain Chart
Image courtesy of Care By Design

“A majority of all patients (72.6%) reported a decrease in pain or discomfort. All patients (100%) with headaches and migraines, fibromyalgia, irritable bowel syndrome (IBS), and spinal cord injury reported a decrease in pain or discomfort. Less than 1% of patients reported an increase in pain or discomfort after CBD-rich cannabis therapy. (All patients reporting an increase in pain reported using CBD for ALS.)”

Cannabis and Mood

“A majority of all patients (64.2%) reported an improvement in mood.  All patients (100%) with PTSD and spinal cord injuries reported an improvement in mood. Some patients with sleep problems (8%) and cancer (3%) reported a worsening of mood. While a majority of patients taking CBD-rich cannabis for “general wellbeing” rather than for a specific medical condition reported improved mood (66.7%), this group was also the most likely to report a worsening of mood (16.7%).”

Cannabis and Energy Levels

Half of all patients (50.4%) reported no change in energy level. The patients most likely to report increased energy levels were those with inflammation (64.0%), fibromyalgia (57.1%), and PTSD (55.6%).  Patients with headaches or migraines were the most likely to report reduced energy levels (37.5%).

The survey was conducted by Care by Design, which sells CBD cannabis sprays, oils and vape cartridges, so the survey has some weaknesses.  A high percentage of survey participants (42%) reported that they did not know the ratio of CBD-to-THC they were taking.

“This report represents preliminary data based on less than one thousand patients. It is not meant to provide patients with guidance on dosing or medical treatment. Rather, it is meant to suggest possible areas for additional research.”

Copyright 2015 National Pain Report

 

The above, with comments, originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus

Previous Previous Page